Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

AbSci (ABSI)

AbSci Corporation
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:ABSI
DateTimeSourceHeadlineSymbolCompany
14/05/202412:35Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ABSIAbSci Corporation
14/05/202412:32Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ABSIAbSci Corporation
14/05/202412:30GlobeNewswire Inc.Absci Reports Business Updates and First Quarter 2024 Financial and Operating ResultsNASDAQ:ABSIAbSci Corporation
16/04/202413:00GlobeNewswire Inc.Absci to Report Business Updates and First Quarter 2024 Financial and Operating Results on May 14, 2024NASDAQ:ABSIAbSci Corporation
28/03/202420:05GlobeNewswire Inc.Absci to Participate in the 23rd Annual Needham Virtual Healthcare ConferenceNASDAQ:ABSIAbSci Corporation
21/03/202411:30GlobeNewswire Inc.Absci Reports Business Updates and Fourth Quarter and Full Year 2023 Financial and Operating ResultsNASDAQ:ABSIAbSci Corporation
01/03/202421:01GlobeNewswire Inc.Absci Announces Closing of Public Offering of Common Stock Including Full Exercise of the Underwriters’ Option to Purchase Additional SharesNASDAQ:ABSIAbSci Corporation
28/02/202421:06Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ABSIAbSci Corporation
28/02/202413:34Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:ABSIAbSci Corporation
28/02/202403:20GlobeNewswire Inc.Absci Announces Pricing of Public Offering of Common StockNASDAQ:ABSIAbSci Corporation
27/02/202421:45Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ABSIAbSci Corporation
27/02/202421:40Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:ABSIAbSci Corporation
27/02/202421:01GlobeNewswire Inc.Absci Announces Proposed Public Offering of Common StockNASDAQ:ABSIAbSci Corporation
21/02/202412:30GlobeNewswire Inc.Absci Initiates IND-Enabling Studies for ABS-101, a Potential Best-in-Class Anti-TL1A Antibody de novo Designed and Optimized Using Generative AINASDAQ:ABSIAbSci Corporation
20/02/202413:00GlobeNewswire Inc.Absci to Participate in Upcoming Investor ConferencesNASDAQ:ABSIAbSci Corporation
13/02/202423:16Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:ABSIAbSci Corporation
06/02/202400:14Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ABSIAbSci Corporation
06/02/202400:14Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ABSIAbSci Corporation
06/02/202400:12Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ABSIAbSci Corporation
06/02/202400:09Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ABSIAbSci Corporation
10/01/202412:30GlobeNewswire Inc.Absci Appoints Professor Sir Mene Pangalos to its Board of DirectorsNASDAQ:ABSIAbSci Corporation
08/01/202412:08Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ABSIAbSci Corporation
08/01/202412:00GlobeNewswire Inc.Absci to Present Preclinical Data for ABS-101, A Potential Best-in-Class Anti-TL1A Antibody Development Program, at 42nd Annual J.P. Morgan Healthcare ConferenceNASDAQ:ABSIAbSci Corporation
04/01/202421:58Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ABSIAbSci Corporation
04/01/202421:57Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:ABSIAbSci Corporation
03/01/202413:00GlobeNewswire Inc.Absci to Participate in the 26th Annual Needham Growth ConferenceNASDAQ:ABSIAbSci Corporation
28/12/202313:00GlobeNewswire Inc.Absci to Participate in the 42nd Annual J.P. Morgan Healthcare ConferenceNASDAQ:ABSIAbSci Corporation
20/12/202313:30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ABSIAbSci Corporation
20/12/202312:30GlobeNewswire Inc.Absci and PrecisionLife Announce Strategic R&D Partnership to Jointly Develop AI-Enabled Drug PipelineNASDAQ:ABSIAbSci Corporation
07/12/202313:30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ABSIAbSci Corporation
 Showing the most relevant articles for your search:NASDAQ:ABSI